PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Osteoporosis and Bone Metabolism Unit, Department of Endocrinology, Singapore General Hospital, Singapore, Singapore. manju.chandran@singhealth.com.sg.\', \'National Public Health and Epidemiology Unit, National Centre for Infectious Diseases, Singapore, Singapore.\', \'Osteoporosis and Bone Metabolism Unit, Department of Endocrinology, Singapore General Hospital, Singapore, Singapore.\', \'Danone Trading Medical B.V, Hoofddorp, The Netherlands.\', \'Department of Endocrinology, Singapore General Hospital, Singapore, Singapore.\', \'Department of Pharmacy, Singapore General Hospital, Singapore, Singapore.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s00198-021-06085-0
?:doi
?:hasPublicationType
?:journal
  • Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
is ?:pmid of
?:pmid
?:pmid
  • 34417842
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Adherence to dosing schedule of denosumab therapy for osteoporosis during COVID-19 lockdown: an electronic medical record and pharmacy claims database study from Asia.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all